IL6R and non-small cell lung carcinoma: Overall, our findings of the anti-proliferative effects of miR-218 in lung adenocarcinima cells, through the direct targeting of IL-6R and JAK3, further corroborate a tumor suppressive role for miR-218 in NSCLC.